Literature DB >> 1198686

An adverse pulmonary reaction to cryoprecipitate in a hemophiliac.

E P Reese, J J McCullough, P R Craddock.   

Abstract

An adult with classif Hemophilia A experienced a very severe reaction to transfusion with cryoprecipitate which was manifested as an adverse pulmonary reaction with marked hypoxemia in spite of oxygen therapy. The patient had neither leukoagglutinins nor lymphocytoxic, anti-platelet, or anti-Gm antibodies. His IgA level was normal. The possibility that debris in the cryoprecipitate from leukocytes and platelets contributed to the reaction is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1198686     DOI: 10.1046/j.1537-2995.1975.15676082234.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

Review 1.  Red blood cell transfusion in the neurological ICU.

Authors:  Monisha A Kumar
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Postpartum immunologic-mediated pulmonary edema associated with transfusion of blood containing an anti-B-lymphocyte antibody.

Authors:  R S Newman; J H Williams; L J Moberg; M L Cook
Journal:  West J Med       Date:  1989-05

Review 3.  Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.

Authors:  Alexander B Benson; Marc Moss; Christopher C Silliman
Journal:  Br J Haematol       Date:  2009-08-05       Impact factor: 6.998

Review 4.  Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations.

Authors:  Kelly Swanson; Denis M Dwyre; Jessica Krochmal; Thomas J Raife
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

5.  Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency.

Authors:  Sabine Kroiss; Manuela Albisetti
Journal:  Biologics       Date:  2010-03-24

6.  Pulmonary complications of transfused blood components.

Authors:  Alexander B Benson
Journal:  Crit Care Nurs Clin North Am       Date:  2012-09       Impact factor: 1.326

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.